Paclitaxel plus gemcitabine may be as active and well tolerated as paclitaxel plus carboplatin for advanced non-small-cell lung cancer

Affiliations

Comment

Yuh-Min Chen. Cancer Treat Rev. 2003 Feb.

. 2003 Feb;29(1):69-71.

doi: 10.1016/s0305-7372(02)00127-5.

¹ Chest Department, School of Medicine, National Yang-Ming University, Taipei Veterans General Hospital, Taiwan. ymchen@vghtpe.gov.tw

No abstract available

Comment on

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, Fountzilas G, Skarlos D, Economopoulos T, Tsavdaridis D, Papakostas P, Bacoyiannis C, Dimopoulos M. Kosmidis P, et al. J Clin Oncol. 2002 Sep 1;20(17):3578-85. doi: 10.1200/JCO.2002.12.112. J Clin Oncol. 2002. PMID: 12202657 Clinical Trial.